The Bodewell line of OTC monograph skin care treatments for eczema and psoriasis returns to US stores five months after Procter & Gamble acquired the brand through its P&G Ventures early-stage startup studio.
Bodewell OTC Eczema, Psoriasis Treatments Relaunched After P&G Ventures’ Acquisition
The line, using colloidal oatmeal for eczema, salicylic acid for psoriasis or pyrithione zinc for flaky scalp, was independently launched in beta by a Vancouver, BC, start-up in January 2020 and debuted in May that year.
More from Retail
• By
Almost two thirds (62%) of respondents to an online survey said they would rather buy non-prescription medicines in a local pharmacy than via a mail-order pharmacy, Pharma Deutschland reports.
• By
Retailer JC Penney Company, Inc.’s use of Revieve Inc.’s virtual try-on and beauty advisor tools has driven significant increases in online engagement, average order rates and conversion rates for makeup, skin and hair care versus the retailer’s other e-commerce products.
• By
Although FDA concluded OTC oral phenylephrine is ineffective as a nasal decongestant in doses up to highest studied level, federal preemption precludes challenges to agency’s regulation of labeling for phenylephrine and other Rx and OTC drugs, according to recent decision in New York federal court.
• By
Firm’s future, as a separate business nearly 90% owned by Bausch Health, or as a standalone with different ownership or one not controlled by a majority owner, claims high profile in analysts’ comments and predictions. B+L is in the driver’s seat, they say.
More from Business
• By
A round-up of the latest consumer health industry appointments: GSCF elects chair; Kenvue hires Northern Europe head; Barentz names chief commercial officer.
• By
Galenica outpaced the growth of the OTC market at home, while recording a double-digit gain abroad, to drive up its consumer health product sales in 2024.
• By
Alliance shareholders overwhelmingly back takeover by DBAY Advisors after improved offer values UK-based firm at £362m.